{"nctId":"NCT01452412","briefTitle":"Alkali Therapy in Chronic Kidney Disease","startDateStruct":{"date":"2011-10"},"conditions":["Chronic Kidney Disease","Metabolic Acidosis"],"count":149,"armGroups":[{"label":"Sodium bicarbonate","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium bicarbonate"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Sodium bicarbonate","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Estimate GFR \\<= 45 and \\>15 ml/min/1.73m2\n* Age \\>18\n\nExclusion Criteria:\n\n* Previous chronic treatment with alkali within the last 3 months (including sodium bicarbonate, calcium carbonate or baking soda)\n* bicarbonate level \\<20 or \\>25 mEq/L\n* New York Heart Association Class III or IV heart failure\n* Systolic blood pressure \\>180 mmHg\n* Initiation of ESRD treatment planned within 6 months\n* Kidney transplantation\n* Treatment with immunosuppressives within the last 3 months","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Sit to Stand to Sit Speed: Time Taken to Sit to Stand to Sit 10 Times","description":"Sit to stand to sit x10 speed (time to perform sit to stand to sit 10 times) will be measured and compared between groups.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.8","spread":"5.8"},{"groupId":"OG001","value":"22.9","spread":"6.5"}]}]}]},{"type":"PRIMARY","title":"DEXA of Wrist","description":"The investigators will evaluate changes in bone mineral density at the wrist.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":"0.23"},{"groupId":"OG001","value":"0.73","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Hand-grip Strength","description":"Hand-grip strength will be measured in all participants","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.3","spread":"9.8"},{"groupId":"OG001","value":"24.9","spread":"10.2"}]}]}]},{"type":"SECONDARY","title":"Estimated GFR","description":"Estimated GFR","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.5","spread":"17.7"},{"groupId":"OG001","value":"36.3","spread":"14.5"}]}]}]},{"type":"SECONDARY","title":"Quality of Life - Physical Function Domain","description":"Short Form- 36 (SF-36) will be performed in all participants. We will evaluate effects on the Physical Function Domain. The Physical Function Domain is scored from 0 to 100 with higher scores meaning better physical functioning.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":"12"},{"groupId":"OG001","value":"43","spread":"11"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":20,"n":74},"commonTop":["Serum potassium >= 5.0 mEq/L","Serum bicarbonate >=30","Serum bicarbonate <=18","Serum potassium <=3.5"]}}}